Imaging tau pathology in Parkinsonisms
Abstract The recent development of positron emission tomography radiotracers targeting pathological tau in vivo has led to numerous human trials. While investigations have primarily focused on the most common tauopathy, Alzheimer’s disease, it is imperative that testing also be performed in parkinso...
Guardado en:
Autores principales: | Sarah Coakeley, Antonio P. Strafella |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6afea461ad4e4fbcb28d678c014008db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
por: Paula Ramos-Gonzalez, et al.
Publicado: (2021) -
Imaging Parkinson’s disease below the neck
por: Per Borghammer, et al.
Publicado: (2017) -
Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
por: Chun Chen, et al.
Publicado: (2021) -
Optimizing Parkinson’s disease diagnosis: the role of a dual nuclear imaging algorithm
por: J. William Langston, et al.
Publicado: (2018) -
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Moxin Wu, et al.
Publicado: (2021)